Skip to main content
Signal8

Anderson Raymond

SEC insider (Form 3/4/5 filer). CIK 0001362489. Director at Monopar Therapeutics (MNPR). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 25, 2026. Located in WILMETTE, IL.

Companies Anderson Raymond has filed insider reports for

  • Monopar Therapeutics (MNPR): Director
Anderson Raymond profile photo

Anderson Raymond

CIK: 0001362489

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (42.9%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monopar Therapeutics logo
MNPR

Monopar Therapeutics

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 25, 2026
    Exercise
    Direct
    1.4K shares at avg. $30.00$42K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 25, 2026
    Exercise
    Direct
    1.7K shares at avg. $30.00$52K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 25, 2026
    Sale
    Direct
    694 shares at avg. $110.04$76K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 25, 2026
    Sale
    Direct
    646 shares at avg. $111.07$72K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 25, 2026
    Sale
    Direct
    1.8K shares at avg. $113.05$204K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 2, 2025
    Award

    Stock Options

    Direct
    2.9K shares-
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Mar 4, 2025
    Award

    Stock Options

    Direct
    11.4K shares-

1-7 of 7